Mutagenic and Cytotoxic Properties of Oxidation Products of 5-Methylcytosine Revealed by Next-Generation Sequencing

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Xing, Xi Wen ^a   Liu, Yu Li ^a   Vargas, Mario ^b   Wang, Yinsheng ^b   Feng, Yu Qi ^a   Zhou, Xiang ^a   Yuan, Bi Feng ^a  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CARBOXYLCYTOSINE; 5 FORMYLCYTOSINE; 5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; BACTERIAL DNA; CYTOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; CHEMICAL ANALYSIS; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DEMETHYLATION; DNA METHYLATION; DNA REPLICATION; DNA SYNTHESIS INHIBITION; ESCHERICHIA COLI; GENE FREQUENCY; GENE MUTATION; IN VIVO STUDY; MUTAGENIC ACTIVITY; NEXT GENERATION SEQUENCING; NONHUMAN; OXIDATION; SEQUENCE ANALYSIS; SHUTTLE VECTOR;

5-METHYLCYTOSINE; ANIMALS; CYTOSINE; DNA METHYLATION; ESCHERICHIA COLI; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; OXIDATION-REDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84884201077     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072993     Document Type: Article

References (35)

1. Ndlovu MN, Denis H, Fuks F, (2011) Exposing the DNA methylome iceberg. Trends Biochem Sci 36: 381-387.
2. Bird A, (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.
3. Rottach A, Leonhardt H, Spada F, (2009) DNA methylation-mediated epigenetic control. J Cell Biochem 108: 43-51.
4. Robertson KD, (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610.
5. Hackett JA, Zylicz JJ, Surani MA, (2012) Parallel mechanisms of epigenetic reprogramming in the germline. Trends Genet 28: 164-174.
6. Wu SC, Zhang Y, (2010) Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 11: 607-620.
7. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935.
8. Kriaucionis S, Heintz N, (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324: 929-930.
9. Ito S, Shen L, Dai Q, Wu SC, Collins LB, et al. (2011) Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine. Science 333: 1300-1303.
10. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, et al. (2010) Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466: 1129-1133.
11. He YF, Li BZ, Li Z, Liu P, Wang Y, et al. (2011) Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333: 1303-1307.
12. Kriukiene E, Liutkeviciute Z, Klimasauskas S, (2012) 5-Hydroxymethylcytosine - the elusive epigenetic mark in mammalian DNA. Chem Soc Rev 41: 6916-6930.
13. Branco MR, Ficz G, Reik W, (2012) Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 13: 7-13.
14. Shen L, Zhang Y, (2013) 5-Hydroxymethylcytosine: generation, fate, and genomic distribution. Curr Opin Cell Biol 25: 289-296.
15. Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, et al. (2012) Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 103: 670-676.
16. Chen ML, Shen F, Huang W, Qi JH, Wang Y, et al. (2013) Quantification of 5-Methylcytosine and 5-Hydroxymethylcytosine in Genomic DNA from Hepatocellular Carcinoma Tissues by Capillary Hydrophilic-Interaction Liquid Chromatography/ Quadrupole Time-of-Flight Mass Spectrometry. Clin Chem 59: 824-832.
17. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, et al. (2010) Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468: 839-843.
18. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, et al. (2013) Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 32: 663-669.
19. Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, et al. (2011) 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 71: 7360-7365.
20. Ito S, Shen L, Dai Q, Wu SC, Collins LB, et al. (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333: 1300-1303.
21. Liu S, Wang J, Su Y, Guerrero C, Mitra D, et al. (2013) Quantitative assessment of Tet-induced oxidation products of 5-methylcytosine in cellular and tissue DNA. Nucleic Acids Res 41: 6421-6429.
22. Pfaffeneder T, Hackner B, Truss M, Munzel M, Muller M, et al. (2011) The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew Chem Int Ed 50: 7008-7012.
23. Raiber EA, Beraldi D, Ficz G, Burgess HE, Branco MR, et al. (2012) Genome-wide distribution of 5-formylcytosine in embryonic stem cells is associated with transcription and depends on thymine DNA glycosylase. Genome Biol 13: R69.
24. Kellinger MW, Song CX, Chong J, Lu XY, He C, et al. (2012) 5-formylcytosine and 5-carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription. Nat Struct Mol Biol 19: 831-833.
25. Lord CJ, Ashworth A, (2012) The DNA damage response and cancer therapy. Nature 481: 287-294.
26. Yuan B, Wang J, Cao H, Sun R, Wang Y, (2011) High-throughput analysis of the mutagenic and cytotoxic properties of DNA lesions by next-generation sequencing. Nucleic Acids Res 39: 5945-5954.
27. Jarosz DF, Beuning PJ, Cohen SE, Walker GC, (2007) Y-family DNA polymerases in Escherichia coli. Trends Microbiol 15: 70-77.
28. Delaney JC, Essigmann JM, (2006) Assays for determining lesion bypass efficiency and mutagenicity of site-specific DNA lesions in vivo. Methods Enzymol 408: 1-15.
29. Neeley WL, Delaney S, Alekseyev YO, Jarosz DF, Delaney JC, et al. (2007) DNA polymerase V allows bypass of toxic guanine oxidation products in vivo. J Biol Chem 282: 12741-12748.
30. Yuan B, Jiang Y, Wang Y, (2010) Efficient formation of the tandem thymine glycol/8-oxo-7,8-dihydroguanine lesion in isolated DNA and the mutagenic and cytotoxic properties of the tandem lesions in Escherichia coli cells. Chem Res Toxicol 23: 11-19.
31. Yuan B, Wang Y, (2008) Mutagenic and cytotoxic properties of 6-thioguanine, S6-methylthioguanine, and guanine-S6-sulfonic acid. J Biol Chem 283: 23665-23670.
32. Yuan B, Cao H, Jiang Y, Hong H, Wang Y, (2008) Efficient and accurate bypass of N2-(1-carboxyethyl)-2'-deoxyguanosine by DinB DNA polymerase in vitro and in vivo. Proc Natl Acad Sci U S A 105: 8679-8684.
33. Munzel M, Lischke U, Stathis D, Pfaffeneder T, Gnerlich FA, et al. (2011) Improved synthesis and mutagenicity of oligonucleotides containing 5-hydroxymethylcytosine, 5-formylcytosine and 5-carboxylcytosine. Chemistry 17: 13782-13788.
34. Nachman MW, Crowell SL, (2000) Estimate of the mutation rate per nucleotide in humans. Genetics 156: 297-304.
35. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, et al. (2010) Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328: 636-639.